Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Kosiborod, a cardiologist, and Skolnik, a family practitioner, agree no single specialty owns that prescription and that "it takes a village to care for a patient."
Monkeypox: What We Know About the Outbreak Now
The CDC reported 1 confirmed case of monkeypox in Massachusetts on May 23rd; Quebec is investigating 17 suspected cases. Find out what we know now about the virus.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Three Doses of Pfizer’s COVID-19 Vaccine Well Tolerated in Children Under 5 Years of Age
Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.
Metformin, Lifestyle in Prediabetes May Reduce Risk of T2D but Not Major CV Events
Among more than 3000 participants with prediabetes, neither metformin or lifestyle change reduced risk for CV events over 21 years according to Diabetes Prevention Program Outcomes Study investigators.
FDA Grants EUA for At-home Triple Test: COVID-19, Influenza, RSV
The Labcorp home test, available without a prescription, is delivered overnight and includes a return envelope. Results are available in 1-2 days.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 23, 2022
Diabetes Device Comparison Made Easy: The Story Behind DiabetesWise Pro
Compare, contrast, price shop, prescribe. DiabetesWise Pro developer Korey Hood, PhD, highlights the tool all primary care clinicians should try.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 20, 2022
Dyspareunia in Women: 10 Questions for Consideration in Primary Care
Dyspareunia significantly impacts quality of life for the women it affects but they may not talk about it. Answer these 10 questions about the condition and you'll be ready to ask.
NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half
In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.
CDC Greenlights COVID-19 Booster for Children Aged 5 to 11 Years
The CDC is encouraging parents of children in this age group to first finish a primary vaccination series, saying only 28% now are in that category.
Review of Biologic Treatments for Asthma Finds Inconsistent Effects on Airway Hyperresponsiveness
ATS 2022: Findings from a literature review provide insight into the mechanisms of airway hyperresponsiveness in asthma.
Early, Consistent Glucose Control May Be Key to CVD Risk Reduction in Type 2 Diabetes: A Primary Care Analysis
In adults with type 2 diabetes seen in primary care, lowering glucose substantially during the first 12 months post-diagnosis decreased risk for future MACE.
Tezepelumab Reduces Asthma Exacerbations by More than Half, Reports NAVIGATOR Study Author
Njira Lugogo, MD, sat down with Patient Care Online to discuss findings from the prespecified exploratory analysis of the NAVIGATOR study that she presented at ATS 2022.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 18, 2022
Real-world Data Showed Mepolizumab Reduced Exacerbations, Oral Corticosteroid Use in Adults with Severe Asthma
ATS 2022: Mepolizumab was effective in reducing asthma exacerbations and oral corticosteroid use in real-world clinical practice, according to new research.
SGLT-2 Inhibitors Belong to Patients, Not a Specialty or Primary Care: Experts Discuss
Mikhail Kosiborod, MD, a cardiologist and Neil Skolnik, MD, a primary care physician, agree that whoever is seeing the patient should prescribe the drug that is needed.
Majority of Asthma Patients Prescribed Dupilumab vs Other Biologics as Initial Rx, According to Extensive Real-world Analysis
ATS 2022: Dupilumab is often the first biologic agent prescribed for moderate-to-severe asthma according to analysis of a US database comprising more than 100 million patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 17, 2022